High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia

BACKGROUND: Acute myeloid leukemia (AML) pertains to a hematologic malignancy with heterogeneous therapeutic responses. Improvements in risk stratification in AML patients are warranted. MicroRNAs have been associated with the pathogenesis of AML. METHODS: To examine the prognostic value of miR-25,...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Mingshan, Feng, Yuan, Zhang, Ninghan, Shao, Tingting, Zhang, Huihui, Wang, Rong, Yao, Yao, Yao, Ruosi, Wu, Qingyun, Cao, Jiang, Liu, Xuejiao, Liu, Yubo, Xu, Kailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505210/
https://www.ncbi.nlm.nih.gov/pubmed/31080363
http://dx.doi.org/10.1186/s12935-019-0843-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505210/
https://www.ncbi.nlm.nih.gov/pubmed/31080363
http://dx.doi.org/10.1186/s12935-019-0843-9

Ejemplares similares